MabThera subkutan 1400 mg/11.7 ml, Lösung zur subkutanen Injektion

7680658130019 CH-65813 Lösung
MabThera subkutan 1400 mg/11.7 ml, Lösung zur subkutanen Injektion
MabThera subkutan 1400 mg/11.7 ml, Lösung zur subkutanen Injektion
MabThera subkutan 1400 mg/11.7 ml, Lösung zur subkutanen Injektion
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
24/11/2023
Summary of Product Characteristics
Français
24/11/2023
Summary of Product Characteristics
Italien
24/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
1400.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 1666.05
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2017

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
65813
Drug name
MabThera subkutan, Lösung zur subkutanen Injektion
Galenic form
LSPA
ATC Code
L01FA01
Authorization status
Z
Dispensing category
A
First authorization
28/06/2016
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Non-Hodgkin Lymphome

Package details

Description (FR)
MABTHERA sous-cutané sol inj 1400 mg/11.7 ml flac
Description (DE)
MABTHERA subkutan Inj Lös 1400 mg/11.7 ml Durchstf
Market launch
28/06/2016
Narcotic (BTM)
No

Other package sizes (1)

MABTHERA sous-cutané sol inj 1600 mg/13.4 ml flac
1 DUR
GTIN: 7680658130026
View